It was aimed to have an even distribution of male and female participants with 40% of each sex recruited into each group
Age shows no clinically meaningful effect on tirzepatide pharmacokinetics across adult age groups in clinical trials
The Role of Tirzepatide and GLP-1 Medications in Fertility GLP-1 receptor agonists, including Tirzepatide, Semaglutide, and Liraglutide, have shown promise in helping individuals lose weight and improve metabolic health (Pavli et al, 2024)
The two trials were randomised, double-blinded, enrolled a total of 3808 adults and evaluated the efficacy and safety of oral semaglutide compared to placebo on top of standard of care
MOUNJARO Use in Combination with Metformin, Sulfonylureas, and/or SGLT2 Inhibitors in Adult Patients with Type 2 Diabetes Mellitus Add-on to metformin SURPASS-2 (NCT03987919) was a 40-week open-label trial (double-blind with respect to MOUNJARO dose assignment) that randomized 1879 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin alone to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or MOUNJARO 15 mg once weekly or subcutaneous semaglutide 1 mg once weekly
Figure 1: Measured changes in HbA1c, body weight, and fasting plasma glucose in response to varying doses of semaglutide, an active control, or a placebo 2) The research team of Davies et